Join a Patient Registry
- October 13, 2020
Would you, or someone you care about benefit from a free, state-of-the-art liver test?
Perspectum is offering a free LiverMultiScan MRI for individuals in select cities.
Why is it important to get your liver checked?
Millions of people across the world are affected by a silent disease (Fatty Liver Disease) that is damaging their internal organs and often goes undetected until it is too late. If liver disease is not diagnosed and treated, it can eventually lead to liver failure and the need for a liver transplant. If liver disease is diagnosed early, it may be possible to halt or even reverse disease progression.
What is a LiverMultiScan?
LiverMultiScan produces a report with measurements of your liver tissue health. This is done using a quick MRI scan that does not require any injections of contrast agents. This report includes a series of pictures and measurements which are linked to levels of fat, iron, inflammation and scarring (fibrosis). The results from LiverMultiScan will help your doctor determine the extent of liver damage and what type of treatment is best for you.
Know Your Risk
- Millions of people may have fatty liver disease not related to alcohol use
- Fatty liver disease is very common in people who are overweight
- Approximately half of people with diabetes have NAFLD
- Obesity and fatty liver disease are both known to increase the risk of severe COVID-19
- Those people with NAFLD and diabetes, high blood pressure and other co-morbidities are known to progress more quickly to NASH
Dallas- Fort Worth area: 18 years and older
Sarasota, Florida: 18 years and older, and have type 2 diabetes
List of Registries - Locations:
Dallas- Fort Worth Metroplex:
- Touchstone Advanced Imaging - Downtown Dallas
- Touchstone Imaging – Southlake
- Partners Imaging Centers
For Dallas: Call (972) 803 - 5501 or email DFWresearch@perspectum.com
For Sarasota: Call (941) 951-2100 or email DiabetesResearch@perspectum.com
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.